NO3057589T3 - - Google Patents

Info

Publication number
NO3057589T3
NO3057589T3 NO14726444A NO14726444A NO3057589T3 NO 3057589 T3 NO3057589 T3 NO 3057589T3 NO 14726444 A NO14726444 A NO 14726444A NO 14726444 A NO14726444 A NO 14726444A NO 3057589 T3 NO3057589 T3 NO 3057589T3
Authority
NO
Norway
Application number
NO14726444A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO3057589T3 publication Critical patent/NO3057589T3/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Saccharide Compounds (AREA)
NO14726444A 2014-05-09 2014-05-09 NO3057589T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/PT2014/000029 WO2015171005A1 (en) 2014-05-09 2014-05-09 (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine

Publications (1)

Publication Number Publication Date
NO3057589T3 true NO3057589T3 (es) 2017-12-30

Family

ID=50819931

Family Applications (1)

Application Number Title Priority Date Filing Date
NO14726444A NO3057589T3 (es) 2014-05-09 2014-05-09

Country Status (29)

Country Link
US (1) US9814712B2 (es)
EP (1) EP3057589B1 (es)
JP (1) JP6768520B2 (es)
KR (1) KR102298676B1 (es)
CN (1) CN106456637B (es)
AU (1) AU2014393490B2 (es)
CA (1) CA2948598C (es)
CY (1) CY1119532T1 (es)
DK (1) DK3057589T3 (es)
EC (1) ECSP16086247A (es)
ES (1) ES2649492T3 (es)
HR (1) HRP20171651T1 (es)
HU (1) HUE035071T2 (es)
IL (1) IL248855B (es)
LT (1) LT3057589T (es)
MA (1) MA39447B1 (es)
MX (1) MX368734B (es)
NO (1) NO3057589T3 (es)
NZ (1) NZ726132A (es)
PH (1) PH12016502233A1 (es)
PL (1) PL3057589T3 (es)
PT (1) PT3057589T (es)
RS (1) RS56591B1 (es)
RU (1) RU2695647C2 (es)
SA (1) SA516380264B1 (es)
SI (1) SI3057589T1 (es)
TN (1) TN2016000498A1 (es)
UA (1) UA118474C2 (es)
WO (1) WO2015171005A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI3831385T3 (fi) * 2014-05-09 2024-09-04 Tecnimede Sociedade Tecnico Medicinal S Pirlindolienantiomeerien mandelaattisuoloja käytettäviksi lääkinnässä
NZ726131A (en) * 2014-05-09 2018-12-21 Tecnimede Sociedade Tecnico Medicinal S (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
EP3392250A1 (en) 2017-04-21 2018-10-24 Tecnimede-Sociedade Tecnico-Medicinal, S.A. Process for the preparation of piperazine ring for the synthesis of pyrazinocarbazole derivatives
EP3392251A1 (en) 2017-04-21 2018-10-24 Tecnimede-Sociedade Tecnico-Medicinal, S.A. Process for the preparation of pirlindole enantiomers and its salts
MX2018011142A (es) 2018-09-13 2019-10-10 Federico Amezcua Amezcua Combinacion farmaceutica sinergica de un inhibidor selectivo de la ciclooxigenasa 2 y un derivado de antraquinona.
EP3900716A1 (en) * 2020-04-21 2021-10-27 Dompe' Farmaceutici S.P.A. Co-crystal of gabapentin, ketoprofen and lysine, pharmaceutical compositions and their medical use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006504795A (ja) * 2002-10-03 2006-02-09 サイプレス バイオサイエンス, インコーポレイテッド 神経学的障害を処置するための抗うつ剤の投薬量の段階的な漸増ならびに毎日の分割した投薬
AU2003292936A1 (en) * 2002-12-24 2004-07-22 Neurochem (International) Limited Therapeutic formulations for the treatment of beta-amyloid related diseases
WO2005025550A1 (en) * 2003-09-15 2005-03-24 Vectura Limited Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
EP1688161A1 (en) * 2004-11-02 2006-08-09 Switch Biotech Aktiengesellschaft Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis
FI3831385T3 (fi) * 2014-05-09 2024-09-04 Tecnimede Sociedade Tecnico Medicinal S Pirlindolienantiomeerien mandelaattisuoloja käytettäviksi lääkinnässä

Also Published As

Publication number Publication date
JP6768520B2 (ja) 2020-10-14
AU2014393490B2 (en) 2020-01-02
CY1119532T1 (el) 2018-03-07
JP2017518979A (ja) 2017-07-13
CN106456637A (zh) 2017-02-22
IL248855A0 (en) 2017-01-31
IL248855B (en) 2020-05-31
SA516380264B1 (ar) 2019-07-29
LT3057589T (lt) 2017-11-27
TN2016000498A1 (en) 2018-04-04
US20170143709A1 (en) 2017-05-25
KR20170002434A (ko) 2017-01-06
KR102298676B1 (ko) 2021-09-07
AU2014393490A1 (en) 2016-11-24
CA2948598A1 (en) 2015-11-12
MA39447B1 (fr) 2018-05-31
RS56591B1 (sr) 2018-02-28
EP3057589B1 (en) 2017-08-02
EP3057589A1 (en) 2016-08-24
CN106456637B (zh) 2020-06-09
SI3057589T1 (sl) 2017-12-29
DK3057589T3 (da) 2017-11-13
NZ726132A (en) 2019-02-22
ECSP16086247A (es) 2017-02-24
HRP20171651T1 (hr) 2017-12-15
RU2016148183A3 (es) 2018-06-13
MX2016014699A (es) 2017-05-02
UA118474C2 (uk) 2019-01-25
RU2016148183A (ru) 2018-06-13
PT3057589T (pt) 2017-11-29
US9814712B2 (en) 2017-11-14
RU2695647C2 (ru) 2019-07-25
PH12016502233A1 (en) 2017-02-06
HUE035071T2 (en) 2018-05-02
MA39447A1 (fr) 2017-10-31
CA2948598C (en) 2021-06-08
MX368734B (es) 2019-10-14
PL3057589T3 (pl) 2018-01-31
WO2015171005A1 (en) 2015-11-12
ES2649492T3 (es) 2018-01-12

Similar Documents

Publication Publication Date Title
JP1539414S (es)
JP1525065S (es)
BR112016019084A2 (es)
BR112016018935A2 (es)
BR112016016536A2 (es)
BR112016015519A2 (es)
BR112016022298A2 (es)
BR112016017429A2 (es)
BR112016022014A2 (es)
BR112016019575A2 (es)
BR112016017337A2 (es)
BR112016022164A2 (es)
BR112016019573A2 (es)
BR112016020096A2 (es)
BR112016018468A2 (es)
BR112016022284A2 (es)
BR112016021768A2 (es)
BR112016021941A2 (es)
BR112016020587A2 (es)
JP1553334S (es)
BR112016015642A2 (es)
BR112016020335A2 (es)
BR112016026882A2 (es)
BR112016020595A2 (es)
BR112016022141A2 (es)